Aptevo names Mary Janatpour chief scientific officer
Reuters2026/08/14 12:05- Aptevo named Mary J. Janatpour as senior vice president, chief scientific officer in its second-quarter 2026 update.
- Janatpour brings more than 25 years of oncology R&D leadership across large biopharma groups and emerging biotech companies.
- She will lead research and preclinical development, supporting clinical priorities, the multispecific pipeline, radiopharmaceutical collaboration, and trispecific solid-tumor programs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Market Chatter: Stellantis Plans to Invest Over 1 Billion Euros to Manufacture New Van in France
U.S. consumer confidence index falls more than expected, inflation expectations rise, Republican satisfaction hits lowest level during Trump's term
At the beginning of September, the consumer confidence index dropped from 51.7 in August to 47.8. Consumers' inflation expectations for the next year jumped from 4% to 4.6%. Most consumers anticipate that the Federal Reserve will raise interest rates within the next year, marking the first time since 2023. Only 35% of Republican respondents believe the government is performing well in economic management, the lowest reading since Trump's return to the White House last year.
Mining Americas switches auditor to Ernst & Young from McGovern Hurley
Mary Chia CFO Su Jun Ming to retire as executive director, step down Sept. 28, 2026
Crypto prices
More
